Vaxcyte, Inc. Common Stock PCVX
$66.70
-9.65%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $116.50
- Implied Upside
- +74.7%
- Price Target Range
- $89.00 – $130.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-05 | BTIGThomas Shrader |
Reiterates | Buy | $89 |
| 2026-10-05 | NeedhamJoseph Stringer |
Maintains | Buy | $110 → $122 |
| 2026-10-05 | GuggenheimSeamus Fernandez |
Maintains | Buy | $116 → $125 |
| 2026-09-28 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $133 → $130 |
| 2026-09-25 | NeedhamJoseph Stringer |
Reiterates | Buy | $110 |
| 2026-02-26 | BTIGThomas Shrader |
Maintains | Buy | $85 → $89 |
| 2026-02-02 | GuggenheimSeamus Fernandez |
Reiterates | Buy | $116 |
| 2026-01-07 | NeedhamJoseph Stringer |
Maintains | Buy | $90 → $110 |
| 2025-11-10 | BTIGThomas Shrader |
Reiterates | Buy | $85 |
| 2025-09-12 | Goldman SachsAsad Haider |
Initiates coverage on | Neutral | $38 |
| 2025-04-22 | Cantor FitzgeraldCarter Gould |
Initiates coverage on | Overweight | — |
| 2025-04-08 | NeedhamJoseph Stringer |
Reiterates | Buy | $90 |
| 2025-04-01 | Goldman SachsChris Shibutani |
Maintains | Buy | $138 → $100 |
| 2025-04-01 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $157 → $137 |
| 2025-04-01 | NeedhamJoseph Stringer |
Maintains | Buy | $140 → $90 |
| 2025-03-12 | GuggenheimSeamus Fernandez |
Reiterates | Buy | $160 |
| 2025-02-26 | GuggenheimSeamus Fernandez |
Reiterates | Buy | $160 |
| 2025-02-26 | NeedhamJoseph Stringer |
Reiterates | Buy | $140 |
| 2025-02-24 | BTIGThomas Shrader |
Reiterates | Buy | $160 |
| 2025-02-11 | NeedhamJoseph Stringer |
Reiterates | Buy | $14 |
| 2024-12-20 | Goldman SachsChris Shibutani |
Initiates coverage on | Buy | $135 |
| 2024-11-06 | Cantor FitzgeraldLouise Chen |
Reiterates | Overweight | — |
| 2024-11-06 | NeedhamJoseph Stringer |
Reiterates | Buy | $140 |
| 2024-09-10 | MizuhoSalim Syed |
Maintains | Outperform | $113 → $163 |
| 2024-09-04 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $101 → $140 |
| 2024-09-03 | Leerink PartnersDavid Risinger |
Maintains | Outperform | $106 → $153 |
| 2024-09-03 | JefferiesRoger Song |
Maintains | Buy | $108 → $129 |
| 2024-09-03 | NeedhamJoseph Stringer |
Maintains | Buy | $95 → $140 |
| 2024-09-03 | BTIGThomas Shrader |
Maintains | Buy | $98 → $160 |
| 2024-08-07 | BTIGThomas Shrader |
Reiterates | Buy | $98 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $66.70
- Market Cap
- $10.98 billion
- 52-Week Range
- $30.81 – $90.75
- Average Volume
- 2.11 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.